Cargando…

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

Detalles Bibliográficos
Autores principales:	Taylor, Kathryn R, Mackay, Alan, Truffaux, Nathalène, Butterfield, Yaron, Morozova, Olena, Philippe, Cathy, Castel, David, Grasso, Catherine S, Vinci, Maria, Carvalho, Diana, Carcaboso, Angel M, de Torres, Carmen, Cruz, Ofelia, Mora, Jaume, Entz-Werle, Natacha, Ingram, Wendy J, Monje, Michelle, Hargrave, Darren, Bullock, Alex N, Puget, Stéphanie, Yip, Stephen, Jones, Chris, Grill, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018681/ https://www.ncbi.nlm.nih.gov/pubmed/24705252 http://dx.doi.org/10.1038/ng.2925

Ejemplares similares

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
por: Carvalho, Diana, et al.
Publicado: (2019)

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma
por: Carvalho, Diana M., et al.
Publicado: (2022)

Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
por: Castel, David, et al.
Publicado: (2015)

DIPG-51. ACVR1 MUTATIONS PROMOTE TUMOR GROWTH IN MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Adorno, Jennifer Ocasio, et al.
Publicado: (2020)

Functional diversity and co-operativity between subclonal populations of paediatric glioblastoma and diffuse intrinsic pontine glioma cells
por: Vinci, Mara, et al.
Publicado: (2018)

DIPG-06. PRECLINICAL EVALUATION OF A NOVEL ACVR1 INHIBITOR IN DIFFUSE INTRINSIC PONTINE GLIOMAS
por: Kumar, Shiva Senthil, et al.
Publicado: (2023)

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
por: Buczkowicz, Pawel, et al.
Publicado: (2014)

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
por: Mackay, Alan, et al.
Publicado: (2017)

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
por: Tauziède-Espariat, A., et al.
Publicado: (2019)

Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma: A Report of the Children’s Oncology Group DIPG Preclinical Consortium
por: Grasso, Catherine S., et al.
Publicado: (2015)

New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis
por: Plessier, Alexandre, et al.
Publicado: (2017)

ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis
por: Hoeman, Christine M., et al.
Publicado: (2019)

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
por: Tauziède-Espariat, A., et al.
Publicado: (2020)

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
por: Olsen, Oddrun Elise, et al.
Publicado: (2015)

Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients
por: Izquierdo, Elisa, et al.
Publicado: (2021)

State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2016)

DIPG-32. AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Jackson, Evangeline R, et al.
Publicado: (2020)

ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma
por: Asnaghi, Laura, et al.
Publicado: (2018)

Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas
por: Pinto, Lia, et al.
Publicado: (2021)

DIPG-35. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) ERADICATION: RESULTS OF THE THREE ARM BIOMARKER-DRIVEN RANDOMIZED BIOMEDE 1.0 TRIAL
por: Grill, Jacques, et al.
Publicado: (2020)

ACVR1 Function in Health and Disease
por: Valer, José Antonio, et al.
Publicado: (2019)

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
por: El-Khouly, Fatma E., et al.
Publicado: (2019)

Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes)
por: Trumpp, Michael, et al.
Publicado: (2023)

HGG-36. HIF-2: A NEW DRUG TARGET IN PEDIATRIC HIGH-GRADE GLIOMA WITH PROMISING PRECLINICAL RESULTS
por: Fuchs, Quentin, et al.
Publicado: (2020)

Glioblastoma Metabolism: Insights and Therapeutic Strategies
por: Bernhard, Chloé, et al.
Publicado: (2023)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
por: Johung, Tessa B., et al.
Publicado: (2017)

Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma
por: Cao, Hongnan, et al.
Publicado: (2020)

IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Madrid, Andres Morales La, et al.
Publicado: (2020)

Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients
por: Petrie, Kirsten A., et al.
Publicado: (2009)

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
por: Lin, Grant L., et al.
Publicado: (2017)

OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma
por: Thomas, Lincy, et al.
Publicado: (2020)

Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
por: Lin, Grant L., et al.
Publicado: (2018)

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology
por: Sabo, Amelia-Naomi, et al.
Publicado: (2021)

Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
por: Benitez-Ribas, Daniel, et al.
Publicado: (2018)

The effect of ACVR1B/TGFBR1/ACVR1C signaling inhibition on oocyte and granulosa cell development during in vitro growth culture
por: AKIMOTO, Yuki, et al.
Publicado: (2023)

Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas
por: Fortin, Jerome, et al.
Publicado: (2020)

Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
por: Benitez-Ribas, Daniel, et al.
Publicado: (2018)

ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children
por: Ho, Assunta CH, et al.
Publicado: (2011)

HGG-39. Integrative analyses of BRAFp.v600e mutated gliomas: from epigenetic to metabolic characteristics
por: Lhermitte, Benoit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ccf80gr6evt6r2lu1putg2jlqc